CeriBell, Inc. (CBLL) vs Enovis Corporation (ENOV)
CeriBell, Inc. and Enovis Corporation are both Medical Devices companies. Enovis Corporation is the larger, with a market value of $1.1B against $914.2M — 1.1× the size. CeriBell, Inc. grew revenue faster over the last twelve months: 31.7% against 4.89%. Enovis Corporation has the higher net margin (−48.0% vs −64.7%) and the higher return on invested capital (−23.6% vs −229.8%). Across the 17 metrics below, Enovis Corporation leads on 9 and CeriBell, Inc. on 8.
Valuation
Profitability
| Metric | CBLL | ENOV | Medical Devices median |
|---|---|---|---|
| Gross margin | 88.90% | 61.09% | 56.01% |
| Operating margin | (68.62%) | (45.14%) | (15.03%) |
| Net margin | (64.73%) | (47.97%) | (20.40%) |
| Free cash flow margin | (55.02%) | 2.77% | (7.24%) |
| Return on equity | (43.93%) | (54.27%) | (15.32%) |
| Return on assets | (35.29%) | (25.07%) | (19.72%) |
| Return on invested capital | (229.76%) | (23.55%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack